Visual information is detected by the retina and transmitted into the brain by retinal ganglion cells. In rodents, the visual thalamus is a major recipient of retinal ganglion cells axons and is divided into three functionally distinct nuclei: the dorsal lateral geniculate nucleus (dLGN), ventral LGN (vLGN), and intergeniculate leaflet. Despite being densely innervated by retinal input, each nucleus in rodent visual thalamus possesses diverse molecular profiles which underpin their unique circuitry and cytoarchitecture. Here, we combined large-scale unbiased proteomic and transcriptomic analyses to elucidate the molecular expression profiles of the developing mouse dLGN and vLGN. We identified several extracellular matrix proteins as differentially expressed in these regions, particularly constituent molecules of perineuronal nets (PNNs). Remarkably, we discovered at least two types of molecularly distinct Aggrecan-rich PNN populations in vLGN, exhibiting non-overlapping spatial, temporal, and cell-type specific expression patterns. The mechanisms responsible for the formation of these two populations of PNNs also differ as the formation of Cat315 + PNNs (but not WFA + PNNs) required input from the retina. This study is first to suggest that cell type-and molecularly specific supramolecular assemblies of extracellular matrix may play important roles in the circuitry associated with the subcortical visual system and in the processing of visual information.
Visual information is transmitted to over forty subcortical regions of the mammalian brain by retinal ganglion cells (RGCs) (Morin and Studholme 2014; Martersteck et al. 2017; Monavarfeshani et al. 2017b) . One such region is the visual thalamus, which consists of three distinct nuclei: the dorsal lateral geniculate nucleus (dLGN), the ventral LGN (vLGN), and the intergeniculate leaflet. While all three nuclei are densely innervated by RGC axons, each is innervated by unique populations of RGC subtypes, of which more than thirty have been identified in rodents (Sanes and Masland 2015; Baden et al. 2016; Rheaume et al. 2018) . Not only do different subtypes of RGCs project to each nucleus, but the anatomical and physiological properties of nerve terminals formed by these RGCs differ significantly in each region (Hammer et al. 2014) : retinal terminals in vLGN are small and functionally weak, whereas those in dLGN are large and elicit strong excitatory post-synaptic potentials in thalamocortical relay cells (Hammer et al. 2014) . Additionally, retinal axons form at least two distinct types of retinogeniculate synapses in dLGN, a characteristic of these axons not found in other retinorecipient nuclei: simple, in which a single large retinal axon synapses onto a relay cell dendrite, and complex, in which many retinal axons converge onto a single dendritic site (Hammer et al. 2015; Morgan et al. 2016) . Moreover, differences in synaptic connectivity between these visual thalamic nuclei are not limited to retinal inputs, as each region is innervated by diverse cohorts of non-retinal axons (Monavarfeshani et al. 2017b) .
The striking differences in connectivity and synaptic architecture in visual thalamic nuclei suggest the existence of target-specific mechanisms that regulate the unique development of synapses and circuits in each region (Monavarfeshani et al. 2018) . Outside of visual thalamus, a diverse number of transmembrane adhesion molecules, growth factors, and extracellular matrix (ECM) proteins regulate the targeting, differentiation, refinement, and maturation of nerve terminals (Waites et al. 2005; Fox and Umemori 2006; Sanes and Yamagata 2009; Yogev and Shen 2014) . Much less is known about molecular signals responsible for the targeting of retinal axons to visual thalamus (Osterhout et al. 2011; Su et al. 2011) , and the molecular mechanisms driving synaptogenesis in these regions (Bjartmar et al. 2006; Stevens et al. 2007; Singh et al. 2012; Monavarfeshani et al. 2018) . To identify synaptogenic cues that may be differentially expressed in vLGN and dLGN, we employed proteomic and transcriptomic analyses of vLGN and dLGN at eye-openinga time-point corresponding to the emergence of nucleusspecific synaptic profiles in visual thalamus (Hammer et al. 2014; Monavarfeshani et al. 2018) .
To our surprise, one set of cues that we identified as being differentially expressed in these regions of visual thalamus were ECM proteins. ECMs are supramolecular structures made up of densely packed proteins and polysaccharides which contribute essential roles in neuronal migration, neural circuit formation, and synaptic plasticity (Dityatev et al. 2010; Dityatev and Rusakov 2011; Frischknecht et al. 2012; Risher and Eroglu 2012; Heikkinen et al. 2014; Smith et al. 2015) . A prominent ECM assembly in the mammalian brain is the perineuronal net (PNN), a lattice-like structure ensheathing the soma and proximal dendrites of subsets of neurons Br€ uckner et al. 1993; Celio and Blumcke 1994; Celio et al. 1998; Yamaguchi 2000) . The molecular composition of PNNs varies throughout the brain. However, key constituents of PNNs include chondroitin sulfate proteoglycans (CSPGs), tenascins, hyaluronan, hyaluronan synthases, and hyaluronan and proteoglycan link proteins (HAPLNs) (Zimmermann and Dours-Zimmermann 2008; Kwok et al. 2010; Frischknecht et al. 2012; Morawski et al. 2012; Sorg et al. 2016) . In many regions of the brain, PNNs primarily ensheath parvalbumin-expressing (PARV + ) GABAergic neurons (H€ artig et al. 1992; Wen et al. 2018) , influencing the function of these inhibitory interneurons and therefore playing a critical role in regulating plasticity (Frischknecht et al. 2009; van't Spijker and Kwok 2017) . There have been conflicting data concerning PNNs in the mammalian visual thalamus; studies in cat identified the presence of Aggrecan-rich PNNs whereas human LGN appears to lack of well-defined PNNs and, instead, contains Aggrecan-rich perisynaptic axonal coats (Sur et al. 1988; Hockfield et al. 1990; Kind et al. 1995; Lendvai et al. 2012) .
Here, our proteomic and transcriptomic profiling data led us away from studying circuit formation and toward exploring the development, distribution, and composition of PNNs in visual thalamus. We discovered that PNNs exist in mouse vLGN but not dLGN. Moreover, two molecularlydistinct populations of PNNs exist within mouse vLGN, each exhibiting distinct regional and cell-specific expression patterns. Lastly, we demonstrate that one population of vLGN PNNs requires the presence of retinal projections for their timely formation, suggesting an activity-dependent mechanism regulating their assembly. Taken together, this study provides a first glimpse into the unique extracellular environment in visual thalamic regions, and raises questions about the roles that ECM molecules and, more specifically PNNs, play in visual circuitry and information processing.
Materials and methods
Aldh1l1-EGFP (stock # 011015-UCD, RRID:MMRRC_011015-UCD) mice were obtained from S. Wang, W. Guido (University of Louisville) and S. Robel (Virginia Tech), respectively. Animals were housed in a temperature -controlled environment, in a 12 h dark/light cycle, and with access to food and water ad libitum. Both males and females were used in these experiments. All animals and experiments were maintained and performed in compliance with National Institutes of Health guidelines and protocols and were approved by the Virginia Polytechnic Institute and State University Institutional Animal Care and Use Committee (IACUC). This study was not blinded and no randomization was performed. No sample calculation was performed. Except where otherwise stated, n=animals and a minimum of three animals per age were compared in all experiments described in this study.
Protein sample preparation
To extract proteins for proteomic analysis, mice were deeply anesthetized by intraperitoneal injection of tribromoethanol (Avertin, 250 mg/kg) and decapitated. dLGN and vLGN tissues were pooled from P12 mice. Dissected tissues were homogenized and lysed in lysis buffer containing 10 mM Tris-HCl, (pH 7.4), 0.15 M NaCl, 1 mM EDTA, 1% sodium dodecyl sulfate (SDS) in phosphate-buffered saline (PBS). Proteins were extracted and delipidated as described previously (Shevchenko et al. 2012) . Icecold acetone/methanol/tri-n butylphosphate (TBP; 12 : 1 : 1) was added to the samples and centrifuged to precipitate proteins. Pelleted proteins were washed with acetone, methanol, and TBP before being air dried. The Micro BCA TM Protein Assay Kit (Pierce, Rockford, IL, USA; #: 23235) was used per the manufacturer's protocol to determine total protein content.
In-gel digestion
Equal amounts (150 lg) of samples were loaded into lanes of a 4%-12% Bis-Tris gel (Bio-Rad Laboratories, Hercules, CA, USA) and were electrophoresed in Tris-Glycine SDS buffer at 150 V constant for 60 min. Gels were stained with colloidal Coomassie Blue, washed in water, and lanes were cut into 11 equal slices and transferred into a 1.5 mL microfuge tube. In-gel digestion on each slice was carried out as described previously (Shevchenko et al. 2006) . Briefly, gel slices were washed in milli Q water for 5 min and washed twice in acetonitrile (ACN)/100 mM NH 4 HCO 3 (50/50) to destain the gels. Proteins were reduced in 10 mM dithiothreitol at 56°C at 600 rpm for 1 h. Slices were washed in water, alkylated with 50 lL of iodoacetamide solution (55 mM in 40 mM NH 4 HCO 3 ), and incubated in the dark for 30 min. Gel slices were washed in water, 50% CAN, and then 100% ACN before being air-dried. Samples were digested in sequencing grade trypsin (Promega; 12.5 ng/lL in 25 mM NH 4 HCO 3 ) and incubated overnight at 37°C. Peptide extraction was performed twice using 50% ACN containing 0.1% formic acid solution. The extracted peptide solutions were pooled and dried using a speed vacuum centrifuge and the peptides resuspended 0.1% formic acid for further LC-MS/MS analysis.
Nano LC-MS/MS
Peptides extracted from in-gel digestion were analyzed by nano-flow liquid chromatography tandem mass spectrometry (nano-LC-MS/ MS) using a LTQ-Velos Orbitrap (Thermo Fisher Scientific, Waltham, MA, USA) mass spectrometer. Chromatographic separation of the peptides was carried out using a Dionex nano-HPLC (Ultimate 3000) with a trapping column (C18, 3 lm, 100 A, 75 lm 9 2 cm) followed by a reverse phase column (C18, 2 lm, 100 A, 75 lm 9 15 cm, nanoViper). Peptides were injected into the trapping column, which was equilibrated with 1% ACN, 0.1% formic acid in MS grade water. Peptides were trapped for 10 min using the loading pump at a flow rate of 3 lL/min, were loaded on to the reverse-phase analytical column, and were eluted using solvents A (2% ACN, 0.1% formic acid in water) and B (98% ACN, 2% water, 0.1% formic acid) at 300 nL/min. A constant gradient was maintained for the first 10 min at 4% solvent B followed by a gradual increase up to 30% solvent B in 20 min. Solvent B was further increased to 60% in 40 min followed by a rapid increase up to 90% over 5 min. The eluted peptides were directed into the nanospray ionization source of the LTQ-Velos Orbitrap with a capillary voltage of $ 1.5 kV. Collected spectra were scanned over the m/z range of 400-2000 using Fourier transform mass spectrometer (FTMS) with resolution of 15000. A second scan was data dependent on the ion trap mass spectrometer (ITMS) with defined settings to choose the ten most intense ions with dynamic exclusion list size of 200, repeat duration of 30 s, repeat count of 2, and explosion duration of 90 s. To generate MS/MS spectra in the second scan, collision-induced dissociation of the peptide ions at normalized collision energy of 35% was utilized.
Protein identification and quantitative data analysis RAW files of LC-MS/MS runs were converted to mzXML format using the ReAdW program (http://tools.proteomecenter.org/wiki/ index.php?title=Software:ReAdW). mzXML spectra files were searched using GPM software (Global Proteome Machine, version 2.1.1; http://www.thegpm.org) (Craig and Beavis 2004) against UniProtKB/Swiss-Prot mouse protein database. Each mzXML spectra file was also searched against a reversed-sequence database to calculate the false discovery rate (FDR) as protein FDR = (# reverse proteins identified)/(total protein identifications) 9 100 (Rabilloud 2003) . Additionally, the peptide FDR was calculated as peptide FDR ¼ 2 Â # reverse peptide identifications total peptide identifications (Krijgsveld et al. 2006) . The 11 output files for each replicate were combined to create a single merged result file, and only proteins with FDR < 1% were used for the analysis. The following parameters were used for the search: enzyme: trypsin; allowed missed cleavage: 2; variable modification: methionine oxidation; fixed modification: carbamidomethylation of cysteine; MS and MS/MS mass tolerance: AE 20 ppm and AE0.2 Da, respectively. For quantitative analysis, normalized spectral abundance factors were used to assess protein abundance (Neilson et al. 2013) . For each identified protein, k, in sample i, the number of spectral counts was divided by the length of the identified protein. NSAF i values for each sample i were obtained by normalizing SpC k /length k values to the total by dividing by the sum (SpC k /length k ) over all proteins. NSAF mean values for all replicates were applied to calculate protein abundance. A spectral fraction of 0.5 was added to the entire spectral counts for each protein to compensate for null values and allow for log transformation of the NSAF data prior to statistical analysis (McDonald 2009 ).
Western blot
After intraperitoneal injection of tribromoethanol (Avertin, 250 mg/ kg), mice were decapitated and dLGN and vLGN regions were rapidly dissected in ice-cold PBS. Each biological sample, composed of pooled tissues at least 5 littermates per group littermates per group, was lysed in modified loading buffer containing 50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol. Samples were homogenized, boiled for 10 min, and their insoluble material was removed. The Micro BCA TM Protein Assay Kit (Pierce #: 23235) was used per the manufacturer's protocol to determine protein concentrations. Equal amounts of protein (30 lg) were loaded and separated by 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane as described previously (Fox et al. 2007) . After blocking polyvinylidene difluoride membranes using 5% non-fat milk in PBS (0.05% Tween), membranes were incubated overnight with primary antibodies ( 
Immunohistochemistry (IHC)
Mice were anesthetized using 12.5 lg/mL tribromoethanol (Avertin) and transcardially perfused with PBS and 4% paraformaldehyde (PFA; pH 7.4). Extracted brains were kept in 4% PFA for 16 h at 4°C, and then incubated for at least 48 h in 30% sucrose. Fixed tissues were then embedded in Tissue Freezing Medium (Electron Microscopy Sciences, Hatfield, PA, USA), and cryosectioned at 16 lm sections on a Leica CM1850 cryostat. Sections were air-dried onto Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA, USA). Sections (n = 3 mice) were allowed to air-dry for 15 min before being incubated in blocking buffer (2.5% bovine serum albumin, 5% Normal Goat Serum, 0.1% Triton-X in PBS) for 1 h. Primary antibodies were diluted in blocking buffer at the following dilutions and incubated on tissue sections at 4°C for 16 h: GAD67 (Millipore MAB5406 In situ hybridization (ISH) Sez6l (clone ID 30362651), Syt1 (clone ID 5363062) cDNAs were obtained GE Dharmacon. Gad1 cDNA (nucleotides 1099-2081) was generated using Superscript II Reverse Transcriptase First Strand cDNA Synthesis kit (# 18064014, Invitrogen, La Jolla, CA, USA) according to the manufacturer manual, amplified by PCR using following primers: F: TGTGCCCAAACTGGTCCT; R: TGGCCGATGATTCTGGTT (Integrated DNA Technologies), gel purified, and then cloned into a pGEM-T Easy Vector using pGEM-T Easy Vector kit, (cat # A1360, Promega, Madison, WI, USA) according to the kit manual. Riboprobes against Gad1, Syt1 and Sez6l mRNAs were generated as described previously (Monavarfeshani et al. 2017a) . ISH was performed on 16 lm PFA-perfused coronally cryosectioned brain tissue (n = 3 mice) prepared as described above. Tissues were prepared and hybridized at 60°C as previously described (Su et al. 2010; Monavarfeshani et al. 2018) . Bound riboprobes were detected by either horseradish peroxidase (POD)-conjugated anti-DIG or anti-fluorescent antibodies (Roche #: 11426346910 and 11207733910), followed by Tyramide Signal Amplification systems (PerkinElmer #: NEL75300 1KT). Slides were visualized on a Zeiss LSM 700 confocal microscope. Images were acquired with identical parameters were used to compare sections from different genotypes.
Quantitative real time PCR (qPCR)
RNA was extracted and purified using the Aurum TM Total RNA Fatty and Fibrous Tissue kit (Bio-Rad #: 7326870) according to the manufacturer's protocol. Each biological sample represented pooled tissues from 5 to 7 animals of the same group. Purified RNA was used to generate cDNA using the Superscript II Reverse Transcriptase First Strand cDNA Synthesis kit (Invitrogen), which was then used as a template. For quantifying relative mRNA expression levels, qPCR was performed on a CFX Connect Real Time System (Bio-Rad) using the iTaq SYBRGreen Supermix (Bio-Rad #: 1725124) according to the manufacturer's protocol. The following cycling conditions were used with 12.5 ng of cDNA: 95°C for 30 s, 42 cycles of amplification at 95°C for 10 s and 60°C for 30 s, and a melting curve analysis. Relative mRNA quantities were determined using the DD-CT method (Schmittgen and Livak 2008) . A minimum of three biological replicates, each ran in triplicate, were processed for each gene of interest. Primers were: Alcam F: TCTGCGA TAAGTATTCCAGAGCAC, R: CAGCCAGTAGACGACACCAG; Calb1 F: TTCATTTCGACGCTGACGGA, R:TCCGGTGATAGCTC CAATCC; Calb2 F: GCTTAAGATCTCCGGAGCGG, R: TGTA CCCATTTCCGTCAGCA; Gad1 F: GCTGACATCGACTGCCA ATA, R: CCATCCAACGATCTCTCTCA; Gad2 F: CAGCCTTAGG GATTGGAACA, R: TCCTTCCTGTTTGACTTCAAGG; Myh11 F: CACGGGGGAGCTGGAAAAG, R: AACTTGCCAAAGCGAGAG GA; Pcdh1 F: GCTCACTGACCGAGAAGGTG, R: AGGAGAA CTTCTGGGTTGTCCA; Sez6l F: ATCTGCCCTCCTGTACGACT, R: TCAAAGGCCTCAAAGCGGAT; Slc8a1 F: GGCACGCTA GCTTTCTCTGTC, R: TGACATTCCGAAGATGGCTCC; Syt1 F: CTCCAGACTACCCCAGCAGA, R: GACAAGGGTCGCAACAGTG; Vglut1 F: GTGCAATGACCAAGCACAAG, R:CGAAGCAAAGACC CCATAGA; Vglut2 F: ATCATCACCCAGATTCCAGG, R: TGGGAT CAGCATATTGAGGG RNA sequencing RNA from dLGN and vLGN was extracted and purified from mice at four different ages (P3, P8, P12, and P25), and processed at the Genomics Research Laboratory at Virginia Tech's Biocomplexity Institute for RNAseq analysis. The RNA sequencing experiment was previously published and the protocol is described in detail in (Monavarfeshani et al. 2018) .
Intraocular CTB injections
Mice were anesthetized with isoflurane, and 1-2 lL of fluorophoreconjugated cholera toxin beta subunit (CTB, Thermo Fisher Scientific C22841)(1 mg/mL) was injected intravitreally (Su et al. 2011) . After 2 days, mice were perfused and fixed with 4% PFA, brains were dissected and sectioned (16 lm) a Leica CM1850 cryostat. Sections were stained as described in IHC section above and finally mounted with Vectashield (Vector Laboratories, Burlingame, CA, USA). Images were acquired on a Zeiss LSM 700 confocal microscope.
Statistical analysis
Unless otherwise stated, results are presented as the mean AE SEM. All statistical analyses were performed using GraphPad Prism 7 (RRID:SCR_002798). Comparisons of expression between different groups in Fig. 5 was determined by performing a two-way analysis of variance (ANOVA test) followed by a Bonferroni post hoc test. All other statistical analyses presented were performed by Student's t-test. No outlier tests or assessments of normality were conducted.
Results
Proteomic and transcriptomic analyses of vLGN and dLGN at eye-opening To investigate proteomic differences in vLGN and dLGN at eye-opening, we micro-dissected each region from wildtype C57BL/6 mouse brains and extracted protein using a protocol that enriches for extracellular and membraneassociated proteins. Protein samples underwent in-gel digestion and extracted peptides were analyzed by nano-flow liquid chromatography tandem mass spectrometry (nano-LC-MS/MS; Fig. 1a ). We identified 1710 proteins that were present in all replicates of vLGN or dLGN samples. To discriminate between the two regions with high confidence, we compared normalized spectral abundance factor (NSAF) values of proteins in either nucleus, and considered p-values ≤ 0.05 as the criterion for significant enrichment (Fig. 1b) . We identified 63 proteins enriched in vLGN and 92 enriched in dLGN. We processed all identified proteins by gene ontology (GO) analysis and found that over 50% of peptides detected were membrane-or ECM-associated proteins by GO analysis (Fig. 1c) .
We next sought to examine the biological correlation and complementarity between these proteomic profiles and a transcriptomic analyses previously performed on vLGN and dLGN at eye-opening (Monavarfeshani et al. 2018) . This integrative approach provides more reasonable insight into tissue-and cell-specific functions for a number of reasons. Firstly, the steady-state expression level of a given gene's mRNA and protein is dependent on a balance between rates of synthesis and degradation, both of which are governed by independent mechanisms. Secondly, mRNA levels do not necessarily correlate with protein abundance (Maier et al. 2009 ). Thirdly, mRNA and protein levels may differ because neurons, and the brain regions they reside in, have far-reaching afferents and efferents. For all these reasons, we mapped a total of 1628 proteins obtained from our proteomics analysis to our previously published RNAseq dataset (Monavarfeshani et al. 2018) (Fig. 2a) . A limitation of this comparison is that the breadth of the proteome accessed by MS was more narrow than that of vLGN and dLGN transcriptomes.
When comparing proteomic and transcriptomic datasets, we observed several trends (which we validated with quantitative real-time PCR [qPCR; Fig. 2b ], immunohistochemistry [IHC; Fig. 2c ], in situ hybridization [ISH; Fig. 2d-f] , and Western Blotting [WB; Fig. 2g]) . We observed cases where enrichment of a given mRNA and its associated protein product were wellcorrelated (in a single region of visual thalamus). This concordance was observed with several genes and proteins, including GAD65 and SEZ6L, whose mRNA are both enriched in one thalamic region (Fig. 2d-f) , and whose proteins are enriched in the same regions (Fig. 2b-g ). However, when mRNA and protein levels appear correlated they are not always generated by the same cell(s). For example, mRNA and protein levels of Vesicular Glutamate Transporter 2 (VGLUT2) were both enriched in dLGN (Fig. 2b and c) , however that enrichment likely originates from different sources. While dLGN relay cells generate Vglut2 mRNA, the translated proteins are transported to their axonal terminals in layer IV of cerebral cortex. Therefore, the bulk of VGLUT2 protein within dLGN is likely not produced by relay cells. Instead, it arises from RGC axon terminals (Land et al. 2004; Hammer et al. 2014) . Thus, the mere fact that the patterns of a given mRNA and protein match in our proteomic and transcriptomic analyses does not necessarily imply generation by the same cell.
Another common pattern that emerged was discrepant expression, meaning a given mRNA or protein was either enriched in one dataset, but not in the other, or that an mRNA and related protein are enriched in opposite regions. For example, glutamate decarboxylase 1 (Gad1) mRNA was enriched in vLGN, but its protein (GAD67) was enriched in dLGN. This was not shocking since the dLGN is densely innervated by inhibitory projection neurons residing in the thalamic reticular nucleus (TRN), but contains significantly fewer local GABAergic interneurons than vLGN (Monavarfeshani et al. 2017b).
The last pattern to emerge was one in which proteomic analysis failed to capture proteins that should have been abundantly enriched in one region. For example, Vesicular Glutamate Transporter 1 (VGLUT1), a protein present within the abundant corticothalamic nerve terminals in dLGN, was absent from this dataset (Fig. 2g) . One possible reason for this is that VGLUT1 proteins could have been lost during the extraction, however that falls short of explaining why similar vesicular associated proteins (i.e. VGLUT2) were successfully captured using the same protocol.
Taken together, these data highlight the importance of cautiously interpreting large-scale proteomic and transcriptomic results when studying neural circuitry. When using this integrative approach of data analysis, discrepancies, rather than being contradictory, provided a context to the cytoarchitecture of vLGN and dLGN.
Select PNN constituents are enriched in the developing vLGN What emerged from proteomic analysis (and re-examination of transcriptomic analysis) was the discovery of an enrichment of ECM proteins, particularly CSPGs and glycoproteins associated with PNNs, in vLGN (Fig. 3a) . This was unexpected, since immunostaining previously showed elevated expression of related ECM molecules, such as Aggrecan (ACAN), in the neonatal mouse dLGN (Brooks et al. 2013) ( Figure S1 ). Here, we found a dramatic and significant increase in the number of mRNA transcripts for Acan across vLGN development (Fig. 3b) , and these expression levels were significantly higher than in dLGN at the same timepoints (Fig. 3b) . To confirm these results, we validated ACAN enrichment at the protein level by both Western Blot (with an antibody that detects the core of ACAN protein; AB1031) and immunohistochemistry (Figs 3c and 4) . (Fig. 3a) . Previous immunohistochemical experiments supported these results as Phosphacan was enriched in vLGN compared to dLGN in neonatal mouse thalamus (Brooks et al. 2013 ). All of these ECM components (or their related family members) are associated with PNNs (Bandtlow and Zimmermann 2000; Yamaguchi 2000) . In our transcriptome analysis, we found other key components of PNNs that were upregulated at eye-opening in vLGN and enriched in vLGN compared to dLGN (Fig. 3b,  d-k) . It is noteworthy that, while PNN components were enriched in vLGN, mRNAs of proteases known to degrade PNNs were enriched in dLGN (Levy et al. 2015) . Specifically, A Disintegrin and Metalloproteinase with Thrombospondin motifs molecules (ADAMTS 1, 8, and 15) were enriched and upregulated in dLGN, potentially contributing to the scarceness of PNN proteins in this region (Fig. 3l-o) .
WFA
+ and Cat315 + PNNs exhibit different spatial and temporal expression patterns in vLGN These results led us to hypothesize that there may be differences in PNN distribution in mouse vLGN and dLGN. To test this hypothesis, we investigated PNNs by immunolabelling with two antibodies directed against ACAN (AB1031 and Cat315, which labels a glycoform of ACAN [Matthews et al. 2002] ) and by labeling PNNs with Wisteria floribunda agglutinin (WFA), an N-acetylgalactosaminespecific lectin (H€ artig et al. 1992, 1994) . We labeled PNNs with these approaches while also labeling retinal terminals in vLGN and dLGN by intraocular injection of fluorescentconjugated Cholera Toxin subunit B (CTB). We identified two molecularly distinct populations of PNNs in visual thalamus: WFA +
Cat315
À PNNs were present in the internal non-retinorecipient region of vLGN (vLGNi, Fig. 4e ), and Cat315 + WFA À PNNs were present in the retinorecipient external region of vLGN (vLGNe; Fig. 4f ). Importantly, both populations of PNNs in vLGN were labeled with AB1031, indicating they all contained ACAN, although the specific glycoforms of ACAN differed in these populations of PNNs. The molecular diversity of PNNs in vLGN was notable, since we found PNNs in most other cortical and subcortical brain regions were immunoreactive to both WFA and Cat315 antibodies (Fig. 4h-l  0 ) . We also found that the development of these distinct PNN populations differs, with WFA + PNNs emerging earlier than Cat315 + PNNs (Figure S1 ). This result was not entirely surprising, given previous reports of the emergence of Cat315-and WFAimmunoreactivity in other brain regions (Ueno et al. 2017) . A final observation was that immunolabeling with AB1031, Cat315, and WFA failed to identify PNNs in the mouse dLGN ( Fig. S4a-d) .
Although PNNs have been reported in the cat visual thalamus, they appear absent from the human LGN, despite the presence of ACAN (Sur et al. 1988; Hockfield et al. 1990; Lendvai et al. 2012) . Instead, in human LGN, ACAN is enriched in perisynaptic axonal coats (Lendvai et al. 2012) . We therefore explored whether the same was true in mouse visual thalamus. In contrast to human LGN, we found little evidence of Cat315 or WFA immunoreactivity in adult mouse dLGN, even outside of PNN-like structures (Figure S2) . Previously, we reported diffuse ACAN was present in neonatal dLGN as retinal axons first invade visual thalamus, but this expression was lost during postnatal development as corticogeniculate axons invaded this thalamic region (Brooks et al. 2013; Seabrook et al. 2013 ) (see also Figure S1 ). Thus, since ACAN is lost in dLGN as retinogeniculate synapses form (Brooks et al. 2013 ) and prior to the formation of other non-retinal synapses (Bickford et al. 2010; Singh et al. 2012; Seabrook et al. 2013) , it seems unlikely that ACAN participates in perisynaptic axonal coats in the neonatal mouse dLGN.
WFA
+ and Cat315 + PNNs ensheath distinct neuronal types in vLGN In many brain regions, PNNs primarily form around inhibitory Parvalbumin-expressing (PARV + ) interneurons (Wen et al. 2018) . We tested whether WFA-or Cat315-immunoreactive PNNs ensheathed PARV + interneurons in vLGN. We labeled PARV + interneurons with either genetic labeling (in Parv-Cre::Thy1-Stop-Yfp mice) or immunostaining with anti-PARV antibodies (Fig. 5 and Figure S3 ). Both approaches revealed a small, regionally-restricted population of PARV + neurons in vLGNe ( Fig. 5a and b and Figure S3 ). Few PARV + neurons were observed in dLGN, but PARV + axonal fibers were observed in this region (Fig. 5c) . Labeling in Parv-Cre::Thy1-Stop-Yfp mice revealed that WFA + PNNs surround the somata and proximal neurites of PARV + neurons in hippocampus, TRN, and visual cortex, as previously reported (H€ artig et al. 1994; Su et al. 2017; Wen et al. 2018) (Fig. 5d-g ). In contrast, PARV + interneurons in vLGN were not ensheathed by WFA + PNNs ( Fig. 5a and b) . We quantified these results and found that, while > 80% of YFP-expressing PARV + neurons were ensheathed by WFA + PNNs, < 10% of WFA + PNNs surround PARV + cells in vLGN (Fig. 5h) . These results were replicated by IHC ( Figure S3 ).
So what type of cells were ensheathed by WFA + PNNs in vLGN? We first ruled out the possibility that WFA + PNNs ensheath glial cells by visualizing astrocytes using an Aldh1l1-GFP reporter and microglia using an antibody against IBA1. As expected, neither cell type was surrounded by WFA + PNNs (Fig. 6a and b) (Fig. 6c-j) . Finally, we asked a more global question of whether WFA + PNNs in vLGN surround neurons at all. Neurons were labeled with antibodies against NeuN, and indeed we found that WFA + PNNs ensheath neurons in vLGN (Fig. 6k-l) . At present, the specific type of neuron wrapped by WFA + PNNs in vLGN remains unknown. We next turned our attention to investigate what cell-types are coated by Cat315 + PNNs. Once again, we used a ParvCre::Thy1-Stop-Yfp transgenic reporter line and assessed the distribution of Cat315 + PNNs (as well as WFA + PNNs). We found both WFA + and Cat315 + ensheathed the same YFP + PARV + neurons in hippocampus, visual cortex, and TRN (Fig. 7a-c) . Although WFA + PNNs were not (or rarely) observed around PARV + neurons, we discovered that PARV + interneurons in vLGN are ensheathed by Cat315 + PNNs (Fig. 7e-f ).
Cat315
+ PNN expression in vLGNe is reduced in the absence of retinogeniculate projections A number of studies have shown that PNNs associated with regions of brain that process visual information, such as in cat visual thalamus and rodent visual cortex, form in an activity and experience-dependent manner (Sur et al. 1988; Kind et al. 1995; Ye and Miao 2013; Ueno et al. 2018) . This led us to test whether the same applies to PNNs in mouse vLGN. We sought to determine whether PNN expression in visual thalamus was impacted by the loss of retinal input. It is worth noting here that the retinal projections to vLGN arrive neonatally and precede the formation of PNNs 
2001). We assessed the distribution of PNNs in Math5
À/À vLGN and found no significant change in the number or intensity of WFA + PNNs (Fig. 8a-c) or in other non-visual regions (Fig. S4) . In contrast, we observed a significant reduction in Cat315 + PNNs in Math5 À/À vLGN in the absence of retinal inputs (Fig. 8d-f ). Thus, a subset of PNNs within visual thalamus requires the presence of retinal inputs (and perhaps visual experience) for their timely formation.
Discussion
Here, we employed an integrative approach for analyzing unbiased proteomic and transcriptomic expression data from visual thalamus at eye-opening. These studies led us to investigate the composition, distribution, and development of PNNs in the LGN. While PNNs were absent from mouse dLGN, we discovered the presence of at least two molecularly-distinct PNNs in vLGN, each exhibiting different spatial and temporal expression patterns, and ensheathing non-overlapping subsets of neurons. Moreover, we found that the assembly of one of these classes of PNNs required the presence of retinal projections, suggesting their formation was activity-dependent. It is worth noting that we were not able to identify many synaptogenic cues (at least previously well-characterized synaptogenic cues) in the developing visual thalamus dLGN ($) with levels at P3 in the same region (Student's t-test). n = 4 mice. Acan -aggrecan; Bcan -brevican; Vcan -versican; Ncanneurocan; Tnr -tenascin-r; Tnc -tenascin-c; Ptprz1 -phosphacan; Hapln1 -hyaluronan and proteoglycan binding link protein 1; Cspg4 -chondroitin sulfate proteoglycan 4; Hspg2 -heparan sulfate proteoglycan 2; Pitg -phosphatidylinositol glycan class A; Adamts8 -A disintegrin and metalloproteinase with thrombospondin motifs 8; Adamts15 -A disintegrin and metalloproteinase with thrombospondin motifs 15; Adamts4 -A disintegrin and metalloproteinase with thrombospondin motifs 4; Adamts1 -A disintegrin and metalloproteinase with thrombospondin motifs 1.
through our proteomic analysis, despite evidence that mRNAs of some such cues are differentially expressed in vLGN and dLGN (Su et al. 2011; Singh et al. 2012; Monavarfeshani et al. 2018) . While advances in proteomics have dramatically contributed to our understanding of the brain proteome, current methodologies still lack the ability to capture the full breadth of peptides present in a sample (Chandramouli et al. 2009 ). For example, while membranebound proteins comprise a remarkable portion of the whole proteome (Wallin and Heijne 1998; Fagerberg et al. 2010) , their identification through proteomic analysis has been challenging due to their unique biochemical properties. Likewise, proteomic approaches fall short in capturing many of the low abundant proteins (Vercauteren et al. 2004; Garbis et al. 2005) . Additionally, the sophistication of neural circuitry, with its intricate architecture and far-reaching fibers, adds another layer of complexity to account for when interrogating nucleus-specific transcriptome and proteome (Ramadan et al. 2017) . However, despite these technical limitations, our proteomic analysis captured a sizeable fraction of ECM-and membrane-associated proteins (Fig. 1c) .
Of the plethora of molecules identified in both of our datasets, we turned our attention to extracellular proteins enriched in vLGN (Fig. 3a) . We took interest in these molecules as our group and others have previously implicated ECM molecules in neuronal circuit formation and plasticity. PNNs were initially found coating cortical interneurons and were thought to function as restrictors of synaptic plasticity in inhibitory interneurons (Dityatev et al. 2010) . A more recent report shows that dense PNN expression around excitatory pyramidal neurons in hippocampus suppresses plasticity (Carstens et al. 2016) . Interestingly, other groups have shown that the window of plasticity can be reopened by degrading PNNs using ChABC in visual cortex and hyaluronidase in auditory cortex ( Pizzorusso et al. 2002; Happel et al. 2014) . In terms of circuit formation, we previously reported a role for ACAN in regulating the timing of corticogeniculate innervation (Brooks et al. 2013 metalloproteases, in visual thalamus development and function (Levy et al. 2015; Rossier et al. 2015) . In fact, ADAMTS4, also known as Aggrecanase 1, is robustly generated in adult mouse visual thalamus by glial cells and by thalamic relay cells in the neonatal thalamus (Levy et al. 2015) . Thus, although we have identified many molecules as being differentially expressed in vLGN and dLGN, we chose to focus on ECM proteins in our study, particularly on PNN components that were significantly enriched in our datasets. A novel contribution of these studies is the identification of two types of PNNs which exhibit different spatial and temporal expression patterns in vLGN and which contain different glycoforms of ACAN. (Fig. 4) . ACAN expression and modification is tightly regulated during development (Matthews et al. 2002; Dino et al. 2006) and is correlated with neural activity (Sur et al. 1988; Guimaraes et al. 1990; Kind et al. 1995; Lander et al. 1997; McRae et al. 2007 McRae et al. , 2010 Figure S5 ). This apparent discord could be due to several reasons. Dark-rearing, while an effective way of eliminating retinal activity, does not impose the same anatomical changes as genetic enucleation. In Math5 À/À mice, retinal progenitors never differentiate into RGCs, preventing the formation of retinogeniculate synapses since early development, thus influencing downstream circuitry including thalamocortical projections and other efferents to visual cortex (Wang et al. 2001; Seabrook et al. 2013; El-Danaf et al. 2015) . It is possible that the genetic removal of retinal inputs could lead to compensatory changes in visual circuits or function. Such changes may promote the normal development of PNNs in Math5 À/ À visual cortex. Finally, it warrants mention that, while we report the activity-dependent regulation of Cat315 + PNNs, our results preclude us from drawing conclusions about whether WFA + PNN expression is regulated by activity since the driving inputs to the region of vLGN occupied by WFA + PNNs (i.e. vLGNi) are not retinal inputs. At present, driving inputs to vLGNi have yet to be defined, making it difficult to remove activity and assess PNN development in this region.
Taken together, the data we present shed new light on the ECM composition of mouse visual thalamus and raise new questions about the role of PNNs in its development and function.
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